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Abstract
Background: Rotavirus is the most common cause of severe gastroenteritis in children under the age of 5 years
worldwide. It is well recognised that rotavirus can cause signs and symptoms beyond the gastrointestinal tract,
including neurological manifestations such as encephalopathy. Mild encephalopathy with a reversible splenial lesion
(MERS) is a clinico-radiological syndrome that has been associated with rotavirus. We report a case of a 4-year-old
boy with clinically mild encephalopathy, who had an isolated splenial lesion in the corpus callosum on
neuroimaging, and rotavirus RNA detected in faeces. We use this case as an opportunity to review the literature on
rotavirus-associated MERS.
Case presentation: A previously healthy 4-year-old boy presented with a 2-day history of vomiting, diarrhoea, and
fever, complicated by reduced level of consciousness. Magnetic resonance imaging of the brain showed a marked
hyperintensity in the splenium of the corpus callosum on T2 and diffusion-weighted images. Rotavirus genome was
detected by polymerase chain reaction in a stool specimen, but not in the cerebrospinal fluid. The genotype was
identified as G1P8. His clinical condition improved with gradual resolution of his symptoms. No neurological
complications were evident upon discharge and the patient had no recurring symptoms or significant residual
defects when followed up 2 months later.
Conclusion: MERS is a novel clinic-radiological syndrome first described in Japan. A transient splenial lesion with
reduced diffusion that appears as a high signal intensity in diffusion-weighted MRI is the main diagnostic feature.
Rotavirus is one of the most common agents associated with MERS, although to our knowledge only one previous
case has been reported from Europe. The majority of patients appear to achieve full recovery following rotavirus-
associated MERS, irrespective of treatment. This case, together with other published reports, supports the
hypothesis that rotavirus-associated MERS is unlikely to be the result of direct viral invasion of the CNS. It has been
suggested that MERS may be caused by intra-myelinic axonal oedema or local inflammatory cell infiltration;
however, the pathogenesis remains incompletely understood.
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Background
Rotavirus is the most common cause of severe gastro-
enteritis in children under the age of 5 years worldwide
[1]. It is well recognised that rotavirus has a viraemic
phase [2] and can cause signs and symptoms beyond the
gastrointestinal tract, including neurological manifesta-
tions such as encephalopathy [3]. We present a case of a
4-year-old boy with clinically mild encephalopathy, who
had an isolated splenial lesion in the corpus callosum on
neuroimaging, and rotavirus RNA detected in faeces.
We use this case as an opportunity to review the litera-
ture on a clinical entity termed rotavirus-associated mild
encephalopathy with a reversible spenial lesion (MERS),
providing insights into the pathogenesis, management,
and prevention of this emerging condition.
Case presentation
A previously healthy 4-year-old boy of Indian origin was
admitted to our hospital with a 2-day history of vomit-
ing, diarrhoea, and fever, complicated by sudden disturb-
ance of consciousness on the day of admission. He was
fully vaccinated (excluding rotavirus vaccine, which was
not a routine component of the UK schedule at the
time), and had no recent history of foreign travel or ani-
mal contact. On admission, he had a temperature of
39.6 °C, heart rate of 155 beats/min, respiratory rate of
30 breaths/min, oxygen saturation of 99 % in room air,
and blood pressure of 92/59 mm Hg. He appeared
mildly dehydrated. He was drowsy with transient periods
of agitation and had a Glasgow Coma Scale score of 13
(eyes 4, verbal 4, motor 5). His parents reported that he
was awake but lethargic. He was unable to recognise
them and lost the ability to make eye contact. He looked
confused, uttered meaningless or incoherent words and
phrases and could not respond to questions in an appro-
priate manner.
Laboratory blood testing showed haemoglobin 11.9 g/dL,
leucocyte count 11,100 cells/μL, platelet count 225,000
cells/μL, serum sodium 131 mmol/L, potassium
4.3 mmol/L, chloride 92 mmol/L, urea 8.3 mmol/L, cre-
atinine 54 μmol/L, alanine aminotransferase 105 U/L, am-
monia 85 μmol/L, and C-reactive protein 25 mg/L.
Cerebrospinal fluid (CSF) examination revealed no
leukocytes, protein 0.15 g/L, and glucose 3.6 mmol/L.
Cranial computed tomography (CT) showed no evi-
dence of an intracranial lesion. Magnetic resonance
imaging (MRI) of the brain performed on day 4 of
hospitalization (6 days after his symptoms began)
showed a marked hyperintensity in the splenium of
the corpus callosum (SCC) on T2 and diffusion-
weighted images with corresponding diffusion restric-
tion on Apparent Diffusion Coefficient (ADC) map-
ping (Fig. 1). Initial electroencephalograph (EEG)
2 days after admission exhibited widespread, excessive
slow wave activity, more prominent in the right
hemisphere. The patient did not experience any sei-
zures, and the abnormality was not evident on a subse-
quent EEG performed 30 days after discharge. Rotavirus
RNA was detected by polymerase chain reaction (PCR)
in a stool specimen, but was not detected in CSF. The
rotavirus genotype was identified as G1P8.
An infusion of intravenous isotonic fluid (0.9 % so-
dium chloride and 5 % glucose) was administered.
Intravenous ceftriaxone, clarithromycin, and aciclovir
were started on the day of admission due to persist-
ent disturbance of the level of consciousness and
suspected acute encephalitis. His clinical condition
improved over the subsequent 5 days, with gradual
resolution of his symptoms, and antimicrobial treat-
ment was discontinued once CSF culture confirmed
no bacterial growth and PCR was reported negative
for herpes simplex virus. No neurological complica-
tions were evident upon discharge. The patient had
not had any recurrence of symptoms when seen for
follow-up 8 weeks later. A follow-up MRI was there-
fore not performed.
Fig. 1 MRI of the brain performed on day 6 of disease a Diffusion-weighted image shows a marked hyperintensity in the SCC. b Corresponding
T2 image. c Corresponding diffusion restriction on Apparent Diffusion Coefficient (ADC) mapping
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Discussion
We describe a previously healthy 4-year-old boy present-
ing with rotavirus gastroenteritis complicated by enceph-
alopathy. Although rotaviruses predominantly infect the
small intestine, neurological manifestations are well de-
scribed, including febrile convulsions, afebrile seizures,
meningoencephalitis, cerebellitis, and encephalopathy
[3]. In our case, the child’s illness was associated with a
specific, isolated MRI lesion with restricted diffusion in
the splenium of the corpus callosum. Tada and co-
workers [4] first proposed a novel clinicoradiological
syndrome in Japan in 2004, characterized by an enceha-
lopathic illness associated with a high-signal intensity in
the splenium. The clinical and radiological changes were
found in association with a range of infections and were
shown to be reversible, leading to the term Mild
Encephalopathy/Encephalitis with Reversible Splenial
Lesion (MERS), for which diagnostic criteria have been
proposed (Table 1). In our case, the finding of acute on-
set of impaired consciousness following an episode of
rotavirus gastroenteritis, in association with an isolated
abnormal MRI signal in the splenium, reversible EEG
changes, and rapid clinical recovery support a diagnosis
of rotavirus-associated MERS, although we did not re-
peat an MRI scan in this child because his symptoms
rapidly and completely resolved.
We undertook a literature search to identify other re-
ports (reviews, case reports or case series) of rotavirus-
associated MERS, using the PubMed database with the
search term “MERS”, “Encephalopathy”, “Encephalitis”,
“Splenium of corpus callosum” and “Rotavirus”. Add-
itional articles were extracted from the references lists of
full publications. For the purpose of this review, we
followed the diagnostic criteria for MERS cited in
Table 1. We found 15 papers published between Septem-
ber 2002 and June 2015. One paper was excluded on the
basis of language [5] and two papers were excluded be-
cause they provided no data on the clinico-radiological
features of MERS [6, 7], leaving 12 reports that were in-
cluded in this review (Fig. 2). We identified 10 case re-
ports [8–17], one case series [18] and one comparative
study [19] for a total of 13 cases of rotavirus-associated
MERS in the English language [8–19]. The case reported
by Kobata et al. [8] was published before the term MERS
was introduced, but it was included in the review since
it met the current criteria for MERS.
Of the 13 cases, 10 were from Japan, one from Korea,
one from China and one from Poland. The median age at
presentation was 2 years (range 1–6 years) with no sex dif-
ference (6 males: 7 females). In all cases, MERS was pre-
ceded by symptoms of gastroenteritis, such as vomiting,
diarrhoea and fever. Hyponatraemia (Na <136 mmol/L)
was reported in 6/13 (46 %) cases. Seizures (9/13; 69 %)
and disturbance of consciousness (8/13; 62 %) were the
most common neurological signs. Abnormal EEG changes
were reported in 5/13 (38 %) cases, with diffuse slow
waves in three and occipital slow waves in two. All abnor-
malities improved on repeat EEG testing.
Twelve patients (92 %) had an isolated lesion in the
splenium of the corpus callosum, and one patient (8 %)
had lesions in the splenium and genu of the corpus cal-
losum. In all cases, the lesions completely reversed
within 12 days (range 5–12 days). All patients recovered
completely (Table 2). In 5 cases in which CSF was tested,
rotavirus RNA PCR alone (n = 3) or in combination with
antigen (n = 2) were negative; RNA and/or antigen were
detected in the serum of two cases. Rotavirus was de-
tected in stool samples from all children; in those for
whom genotyping was performed, genotypes identified
were G1 (n = 2), G3 (n = 2), G9 (n = 1), and G5 (n = 1).
In the present case, a repeat MRI was not performed,
because the SCC lesion was initially thought to represent
terminal myelination rather than pathology. The possi-
bility of MERS was considered retrospectively and by
this point the patient had fully recovered clinically, such
that a repeat MRI scan under general anaesthesia could
not be justified.
Other possible differential diagnoses of acquired le-
sions of the corpus callosum include infarction, tumours
(lipoma, lymphoma, glioblastoma), multiple sclerosis,
Marchiafava-Bignami disease, trauma-associated diffuse
axonal injury, Posterior Reversible Encephalopathy Syn-
drome (PRES), acute encephalopathy associated with
intravenous immunoglobulin therapy, hydrocephalus,
antiepileptic drugs (AED), alcoholism, malnutrition,
hypoglycemia, hyponatraemia, hypernatraemia and her-
editary disorders of myelination (Krabbe's disease, X-
linked adrenoleukodystrophy) [20, 21]; however, these
were excluded clinically and radiologically in our patient.
Acute disseminated encephalomyelitis (ADEM) should
be considered in the differential diagnosis of patients
with MERS lesions. In ADEM, the lesions seen in the
corpus callosum are usually asymmetrical and contrast-
enhancing, extend to the white matter and resolve over
weeks to months; by contrast, in MERS the lesions show
Table 1 Diagnostic criteria of MERS
1. Onset with neuropsychiatric symptoms, such as abnormal speech
and/or behaviour, and impaired consciousness and convulsion, within
1 week after the onset of fever.
2. Complete recovery without sequelae, mostly within 10 days after the
onset of neuropsychiatric symptoms.
3. High-signal-intensity lesion in the splenium of corpus callosum, in the
acute stage. T1 and T2 signal changes are mild.
4. Lesion may involve the entire corpus callosum and the cerebral white
matter in a symmetric fashion.
5. Lesion disappears within 1 week, with neither residual signal changes
nor atrophy.
Source: (Hoshino et al. [6], 2012, p.338 Table 1)
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Table 2 Rotavirus-associated MERS in children: review of the literature (Continued)
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no contrast enhancement and mostly disappear quickly
[4]. Although our patient did not have a repeat brain
MRI, the clinical course of his disease makes the diagno-
sis of ADEM unlikely. An isolated splenial lesion associ-
ated with rotavirus gastroenteritis is not always a benign
sign. Patients with rotavirus cerebellitis have been re-
ported to have transient splenial changes in the acute
phase identical to those found in MERS [22]. Rotavirus
cerebellitis concurrent with encephalitis is typically com-
plicated by mutism with subsequent dysarthria and
neurological sequelae, and MRI imaging shows chrono-
logical changes that involve the cerebellar cortex and re-
sult in cerebellar atrophy [22].
Management of rotavirus-associated MERS varies in
the literature. Five patients (38 %) were treated with ste-
roids, with no side-effects reported. One patient (8 %)
received antimicrobial therapy for suspected meningo-
encephalitis. Anticonvulsant drugs were given to 5
(38 %) patients mainly as rescue management. Isotonic
fluids were given in 7/13 (54 %) cases and an osmotic di-
uretic in 4/13 (31 %). All patients with rotavirus-
associated MERS made a full clinical recovery, so it is
difficult to compare the efficacy of these different man-
agement approaches. Given its generally benign progno-
sis, specific immunomodulatory treatment for rotavirus-
associated MERS may not be justified. However, sup-
portive care may include antimicrobial cover for more
serious causes of meningoencephalitis, such as herpes
simplex virus infection, until the diagnosis of MERS is
made; control of seizures with anticonvulsants and judi-
cious fluid administration to correct dehydration and
electrolyte imbalances secondary to rotavirus gastro-
enteritis, particularly since hyponatraemia has been hy-
pothesized to contribute to the pathogenesis of MERS.
The pathogenesis of rotavirus-associated neurological
disease is still incompletely understood. Detection of
rotavirus RNA by PCR from CSF of some patients with
neurological complications supports a hypothesis of dir-
ect viral invasion [23]. However, the significance of this
finding remains unclear. It has generally been believed
that rotavirus is localized to the epithelial cells of the
small intestine, although a series of studies has demon-
strated that rotavirus infection in children results in
antigenaemia and viraemia during the acute phase of the
disease [2]. These findings highlight the fact that extra-
intestinal dissemination of rotavirus can occur, but the
association between rotavirus viraemia and CNS compli-
cations is not clearly demonstrated. Detection of rota-
virus RNA in CSF did not correlate with the presence of
rotavirus antigen in CSF in a study by Nakagomi and
Nakagomi [24]. It is also possible that CSF contamin-
ation with diarrhoeal stools could occur at the time of
lumbar puncture or during laboratory handling [23].
There are no reports of detection of rotavirus RNA from
the CSF of patients with rotavirus-associated MERS,
suggesting that direct invasion is unlikely to be the
pathogenic mechanism. In addition, MERS is also caused
by other pathogens, including influenza virus A and B,
mumps virus and adenovirus [6].
It has been hypothesised that intramyelinic oedema or
inflammation of the corpus callosum may play a role in
the pathogenesis of MERS [7]. Since hyponatraemia is
common in MERS, including the present case, cerebral
oedema secondary to hypotonic dehydration is a possible
mechanism. This hypothesis is supported by data from
two other conditions. First, a completely reversible sple-
nial lesion has been described in patients on antiepilep-
tic drugs, usually when the dose is reduced quickly,
possibly caused by a transient change in water balance
due to the effect these drugs have on electrolyte chan-
nels [25]. Second, similar splenial changes have been
found in patients with high-altitude cerebral oedema,
where hypoxia causes vasogenic interstitial oedema [26].
A water-electrolyte imbalance may therefore be a com-
mon mechanism underlying these three conditions;
however, hyponatraemia is not universal in cases of
MERS [7]. Another possible explanation is a local infil-
tration of inflammatory cells. Interleukin-6 (IL-6) and
nitric oxide metabolites may have an important role in
the pathophysiology of MERS [27]. Although elevated
serum IL-6 appears to have good predictive value for the
clinical severity of influenza virus-associated encephal-
opathy [28], IL-6 measurements have not been per-
formed in sufficient MERS cases for any conclusions to
be drawn. A small study showed increased CSF levels of
IL-6 and IL-10 in three of six patients with MERS, of
whom two had lesions extending to the white matter
[27]. The rotavirus non-structural protein 4 (NSP4) in-
duces nitric oxide metabolites, which are highly reactive
free radicals [29]. Nitrites and nitrates have been re-
ported to be raised in both serum and CSF of patients
with rotavirus-associated seizures, but the report in this
study did not describe outcomes based on the presence
or absence of splenial changes [30]. Taken together,
MERS is a rare syndrome of uncertain pathogenesis; des-
pite a number of plausible hypotheses, none explains
why the splenium is the site that is specifically involved.
Rotavirus immunisation is now recommended by the
World Health Organization, and has recently been intro-
duced in the UK. Payne and colleagues [31] reported an
unexpected benefit of rotavirus vaccination in the USA.
A retrospective analysis of 250,601 infants showed that a
full rotavirus vaccination course was associated with an
18–21 % decrease in the risk of seizures during the first
year after vaccination, suggesting that rotavirus infection
may be an under-recognized cause of neurological dis-
ease. Extrapolating findings from this study, it is bio-
logically plausible that rotavirus vaccination may also
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reduce other neurological manifestations of rotavirus in-
fection. With the exception of one case, which was asso-
ciated with the G5P6 genotype, all other reported cases
of rotavirus-associated MERS (including the present
one) were associated with rotavirus genotypes that are
covered by the available vaccines.
Conclusions
Although the burden of disease has decreased significantly
in countries where vaccination has been introduced, rota-
virus is still a common cause of hospitalization [32] in de-
veloped countries and it should be considered in the
differential diagnosis of a child with encephalopathy or en-
cephalitis, particularly if associated with a diarrhoeal dis-
ease [33]. MERS has been increasingly recognized as a
clinical entity in Japan, where it was first described, with
only few cases reported to date outside of East Asia. A re-
cent study by Ka et al reported seven cases of MERS in
Caucasian Australian children, related to various infec-
tious or inflammatory triggers, although none had rota-
virus infection [34]. It is likely that MERS is under-
diagnosed, since the diagnosis of this condition relies on
MRI. The outcome of rotavirus-associated MERS is good,
with the majority of patients achieving full recovery irre-
spective of treatment. However, it is important to be aware
that rotavirus infection is also associated with more severe
neurological complications, such as acute cerebellitis,
which might also present with an isolated splenial lesion.
This case, together with the other published case reports,
supports the hypothesis that rotavirus-associated MERS is
unlikely to be the result of direct viral invasion of the
CNS. However, the pathogenesis of MERS remains un-
clear, and a further understanding of its mechanisms is
required.
Consent
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